Nasenspray Erwachsene (Xylometazoline Hydrochloride)

Xylometazoline hydrochloride, the active ingredient in Nasenspray Erwachsene, is an alpha‑adrenergic agonist presented as a nasal spray for nasal administration. It works by constricting blood vessels in the nasal mucosa, providing rapid relief of nasal congestion and pressure in adult patients suffering from colds, allergies, or sinusitis.

GNH USA supplies Nasenspray Erwachsene as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU quality standards and is available for bulk and retail distribution.

Xylometazoline hydrochloride is a topical nasal decongestant used to alleviate swelling of the nasal passages.

- Nasal congestion: reduces mucosal edema and improves airflow. - Common cold: eases blockage caused by viral infection. - Allergic rhinitis: relieves congestion associated with allergen exposure.

Adverse reactions may occur with any nasal decongestant. Most are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation. - Dryness of the nasal mucosa. - Sneezing. - Headache.

Serious or Rare Side Effects: - Rebound congestion (rhinitis medicamentosa) after prolonged use. - Severe hypertension or arrhythmia. - Allergic reactions such as rash, swelling, or anaphylaxis. - Nasal ulceration or tissue damage.

Use Nasenspray Erwachsene with attention to duration and frequency to avoid complications.

- Do not exceed recommended frequency: limit to 2 sprays per nostril every 12 hours. - Avoid prolonged use: discontinue after 3‑5 days to prevent rebound congestion. - Consult a healthcare professional if pregnant or breastfeeding. - Keep out of reach of children. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Xylometazoline may interact with systemic or topical agents that affect vascular tone.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Tricyclic antidepressants: additive vasoconstrictive effect. - Beta‑blockers: may enhance blood‑pressure elevation.

Moderate Interactions (Monitor Closely): - Nasal antihistamines: may increase local irritation. - Other nasal decongestants: risk of cumulative vasoconstriction.